No evidence for maternal-fetal microchimerism in infantile hemangioma: A molecular genetic investigation

Journal of Investigative Dermatology

Volumn 126, Issue 11, 2006, Pages 2533-2538

  Pittman, Kristianna M ^a   Losken, H Wolfgang ^b   Kleinman, Mark E ^a   Marcus, Jeffrey R ^c   Blei, Francine ^d   Gurtner, Geoffrey C ^a   Marchuk, Douglas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE TRANSPORTER 1;

ARTICLE; CANCER SURGERY; CELL PROLIFERATION; CELL SPECIFICITY; CHIMERA; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HEMANGIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFANT DISEASE; MALE; MATERNAL FETAL MICROCHIMERISM; MICROSATELLITE MARKER; MOLECULAR GENETICS; MOTHER CHILD RELATION; PATHOGENESIS; PLACENTAL ORIGIN THEORY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THEORY CONSTRUCTION;

CHIMERISM; DNA, COMPLEMENTARY; ENDOTHELIUM, VASCULAR; FEMALE; FETUS; GENOTYPE; GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MICROSATELLITE REPEATS; PLACENTA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RECEPTORS, IGG; SEQUENCE ANALYSIS, DNA;

EID: 33750055302     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700516     Document Type: Article

References (14)

1. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356:2155-6
2. Barnes CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS et al. (2005) Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 102:19097-102
3. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J (2001) Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745-52
4. Burton BK, Schulz CJ, Angle B, Burd LI (1995) An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenatal Diag 15:209-14
5. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR (2003) Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 88:1384-8
6. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP et al. (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185-9
7. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC et al. (1999) Microchimerism of maternal origin persists into adult life. J Clin Invest 104:41-7
8. North PE, Waner M, Mizeracki A, Mihm MC Jr (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11-22
9. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J et al. (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137: 559-570
10. Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M (2002) Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 99:7455-60
11. Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Friedlander DF et al. (2003) Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol 1:291-9
12. Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW (2003) Maternal cell microchimerism in newborn tissues. J Pediatr 142:31-5
13. Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JW et al. (2002) Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 33:295-303
14. Yu Y, Wylie-Sears J, Boscolo E, Mulliken JB, Bischoff J (2004) Genomic imprinting of IGF2 is maintained in infantile hemangioma despite its high level of expression. Mol Med 10:117-23